
UAE-Based M42 Enters African Market Through Ten-Year Healthcare Partnership in Botswana
UAE-based M42 has marked its first health systems entry into Africa by signing a ten-year strategic partnership with Botswana's Ministry of Health. The agreement focuses on digital health transformation, genomics, precision medicine, and strengthening the national medical supply chain.
UAE-based M42 has officially entered the African market through a ten-year strategic partnership with Botswana's Ministry of Health, designed to support the country's healthcare system through advanced medical technologies. Signed in Gaborone, the agreement represents M42's first major health systems partnership on the continent and centers on digital health transformation, a national genomics programme, precision medicine, and the development of local and regional healthcare capabilities over the coming decade.
The formal signing ceremony took place in the presence of Botswana's Minister of Health Dr Stephen Modise and Kareem Shahin, who serves as CEO of M42's Digital Health Solutions platform and Group Chief Digital Officer. Acting Permanent Secretary Dr Tshepo Machacha signed the agreement on behalf of the Botswana Government. This collaborative framework was established shortly after Botswana's Parliament approved the National Health Insurance Policy on August 19, an institutional milestone aimed at achieving universal health coverage and delivering affordable healthcare regardless of a patient's income or geographic location.
Beyond digital infrastructure, the collaboration involves M42 and Mubadala Bio working directly with Botswana to enhance the flow of medicines and medical equipment. The operational scope aims to construct a more reliable medical supply chain, elevate access to essential healthcare products, and streamline procurement channels nationwide. Minister Modise emphasized that the initiative focuses heavily on fortifying health security, establishing resilience within supply chains, and preventing delays that could leave patients without necessary medical products.
Drawing on institutional capabilities in artificial intelligence, clinical care, and genomics, the ten-year initiative seeks to address Botswana's long-term healthcare needs. Dimitris Moulavasilis, Group Chief Executive of M42, noted that the agreement creates an avenue to deploy the organization's full technical scope to support national health priorities. Meanwhile, Shahin affirmed that M42 teams will collaborate directly alongside Botswana's Ministry of Health and local medical professionals to ensure technologies function effectively and care reaches communities across the entire country.
Why This Matters
Entering the African health sector through a ten-year commitment signals a structural shift in how public health infrastructure can integrate advanced technological frameworks like artificial intelligence and national genomics programmes. By aligning directly with newly approved national health insurance policies, this long-term arrangement bridges the gap between state-level universal healthcare ambitions and specialized private sector operational capabilities. Building resilience into medical supply chains addresses historical bottlenecks that often disrupt clinical delivery in Southern Africa, establishing a replicable model for public-private cooperation.
Furthermore, embedding precision medicine and digital health solutions within a public framework requires robust operational alignment between incoming international operators and local regulatory bodies. The success of this ten-year partnership depends heavily on the continuous transfer of skills to domestic healthcare professionals and the creation of sustainable administrative pathways. As governments across the region pursue universal coverage, strategic engagements that simultaneously tackle supply chain reliability and advanced clinical diagnostics will likely shape future health sector investments across the continent.
Opportunities
- Medical Contractors: Opportunities to participate in upgrading physical health facilities and streamlining logistics networks to support the expanded national supply chain.
- Technology Integrators: Commercial openings to deploy and maintain digital health platforms, artificial intelligence tools, and data infrastructure required for the national genomics programme.
- Pharmaceutical Suppliers: A clear channel to supply essential medicines and medical equipment through modernized, more efficient procurement pathways established by M42 and Mubadala Bio.
- Healthcare Professionals: Training and capacity-development engagements for local clinical staff working alongside international specialists in precision medicine.
Moto Seen Africa - Africa's View, Seen Clearly
#MotoSeenAfrica #SeenAfrica #SeenNetwork #AfricasView #SeenClearly #SeenInsights #DigitalHealth #Genomics #PublicHealth #BotswanaBusiness
SHAHID YAKUB
Seen Africa Newsroom


